Anolyte K for Coulometry coulometric Karl

Hazard statements (CLP)

H226, H302, H314, H318, H331, H351, H360FD, H370, H372, H373

Code

Statements

H226

Flammable liquid and vapour

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Flammable liquids, (Category 3) H226: Flammable liquid and vapor. Acute toxicity, (Category 4) H302: Harmful if swallowed. Acute toxicity, (Category 3) H331: Toxic if inhaled. Skin corrosion, (Sub-category H314: Causes severe skin burns and eye 1C) damage. Serious eye damage, (Category H318: Causes serious eye damage. 1) Carcinogenicity, (Category 2) H351: Suspected of causing cancer. Reproductive toxicity, (Category H360FD: May damage fertility. May 1B) damage the unborn child. Specific target organ toxicity - H370: Causes damage to organs. single exposure, (Category 1), Immune system Specific target organ toxicity - H372: Causes damage to organs through repeated exposure, (Category 1), prolonged or repeated exposure if Liver, Kidney swallowed. Specific target organ toxicity - H373: May cause damage to organs repeated exposure, (Category 2), through prolonged or repeated exposure. thymus Specific target organ toxicity - H373: May cause damage to organs repeated exposure, (Category 2), through prolonged or repeated exposure if Blood inhaled. 2.2

2.2 Label elements

Labelling

Signal word

Danger Danger

Hazard statements

H226 Flammable liquid and vapor. H302 Harmful if swallowed. H314 Causes severe skin burns and eye damage. H331 Toxic if inhaled. H351 Suspected of causing cancer. H360FD May damage fertility. May damage the unborn child. H370 Causes damage to organs (Immune system). H372 Causes damage to organs (Liver, Kidney) through prolonged or repeated exposure if swallowed. H373 May cause damage to organs (thymus) through prolonged or repeated exposure. H373 May cause damage to organs (Blood) through prolonged or repeated exposure if inhaled. Restricted to professional users. For use in industrial installations only. Reduced Labeling (<= 125 ml) H331 Toxic if inhaled. H351 Suspected of causing cancer. H370 Causes damage to organs. H372 Causes damage to organs through prolonged or repeated exposure if swallowed. H314 Causes severe skin burns and eye damage. H360FD May damage fertility. May damage the unborn child. 2.3

Precautionary statements

P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/ doctor. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/ doctor. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

Supplemental label elements

none none

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. SECTION 3: Composition/information on ingredients